Mission3 is now arivis

Phoenix, AZ – January 20, 2015 – Mission3, a leading provider of cloud-based and enterprise regulatory information management, clinical trial master file, and promotional materials management solutions for the life sciences industry, is changing its name to arivis in coordination with its parent company arivis, AG. arivis will combine Mission3’s cloud-based Clireo product and regulatory services as well as its enterprise GlobalTrack regulatory information management (RIM) product with arivis AG’s high-resolution, 3D+ image management solution to provide a high-value portfolio of solutions for life science, academic research, and healthcare clients.

Continue reading

CFAST Launches Two New CDISC Therapeutic Area Standards for Influenza and QT Studies

The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. (“TransCelerate”) announced today that version 1.0 of the CDISC Influenza Therapeutic Area User Guide (TAUG) and version 1.0 of the CDISC QT Studies TAUG are now available for implementers on the CDISC website. CDISC standards facilitate clinical research from end-to-end, from protocol and data collection through analysis and reporting, and have been shown to significantly decrease the time and cost of medical research while improving quality.Continue reading